Ibandronate Sodium, marketed as Bonviva, is used to treat osteoporosis in postmenopausal women and reduce the risk of fractures.
Bonviva, produced by Roche Chemicals and Pharmaceuticals, can be purchased from pharmacies in the form of tablets or injectables.
Bonviva price
The price of Bonviva varies between 120 and 300 reais.
Bonviva Indications
Bonviva is indicated for the treatment of osteoporosis, which is characterized by post-menopausal bone weakening to reduce the risk of vertebral fractures.
How to use Bonviva
The mode of use of Bonviva consists of the ingestion of 1 150 mg tablet per month, fasting, 60 minutes before the first food or drink of the day, except water, and before the administration of any other medicine or supplement, including calcium, and tablets should always be taken on the same date each month.
The tablet should be taken with a full glass of filtered water and should not be taken with another type of drink such as mineral water, sparkling water, coffee, tea, milk or juice, and the patient should take the tablet standing, sitting or should not lie down within 60 minutes of taking the tablet.
Bonviva side effects
The most common side effects of Bonviva include diarrhea, abdominal pain, nausea, difficulty in digestion, gas, gastroesophageal reflux, gastritis, esophagitis, headache, flu, tiredness, muscle and joint pain, cramps, muscle stiffness and redness of the skin .
Contraindications of Bonviva
Bonviva is contraindicated in patients with hypersensitivity to the components of the formula in patients with uncorrected hypocalcemia, ie with low levels of calcium in the blood, in patients unable to stand or sit for at least 60 minutes, and in patients with esophageal problems, such as delayed esophageal emptying, narrowing of the esophagus, or lack of relaxation of the esophagus.
This medication should not be used by pregnant women during breast-feeding in children and adolescents under 18 years of age and in patients who are using non-steroidal anti-inflammatory drugs without medical advice.
